Issue 102

The MHRA’s Innovation Passport

For The Psychedelics as Medicine Report: Fourth Edition, PSYCH spoke with the UK’s Medicines and Healthcare products Regulatory Agency (MHRA).

The MHRA has granted these passports to therapies harnessing MDMA, psilocybin and DMT.

‘The MHRA is the body that regulates medicines and medical devices in the UK. We play a leading role in protecting and improving public health and support innovation through scientific research and development.

‘This is an age of change, and we see ourselves as a collaborative and enabling regulator that looks for opportunities to support innovative new products and ways of working.’

ALBERTA TO LICENCE PSYCHEDELIC THERAPISTS

In 2023, medical practitioners will be able to apply for a licence to conduct psychedelic-assisted therapy.

CLERKENWELL HEALTH RAISES £2.1M

The UK is positioned to become a leader in psychedelic research, with industry-leading organisations based there.

BUSINESS AND INVESTMENT

Optimi Health raises US$1.85 million.

DMT studied as a stroke treatment in the Netherlands.

Numinus develops psilocybin-containing tea bag.

MDMA-assisted therapy for alcohol use disorder.

The efficacy of LSD for anxiety disorders.

Oregon psilocybin services facilitator training.

SCIENCE AND RESEARCH

Researchers build virtual library of 75 million psychedelic compounds.

The antidepressant mechanism of ketamine.

Ketamine for neonatal and paediatric refractory status epilepticus.

On Thursday 17 November, PSYCH Investor Summit: London 2022 will connect a qualified investor community with business leaders driving innovation in psychedelic healthcare.

The event coincides with the release of The Psychedelics as Medicine Report: Fourth Edition, the industry’s leading data and insights publication and Jefferies 2022 London Healthcare Conference.

For partnership opportunities, please contact grace@psych.global

CONTACT FORM

REGULATION AND LEGISLATION

New York lawmakers file amended psychedelic legalisation bill.

Psilocybin licences for non-Oregon residents.

Psilocybin services proposed in New Jersey.

ARTICLES OF INTEREST

£122m fund for people receiving mental health support.

MHRA and NICE receive £1.8m to regulate digital mental healthcare.